ANIDULAFUNGIN Labatec subst sèche 100 mg flac
7680677560019
CH-67756
J02AX06
08.06.0.
Reimbursement limitations:
ECALTA2
Traitement des candidémies et des formes invasives de la candidose chez les patients adultes récemment …
1 / 3
google
Details
- Product number
- 6775601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum 100 mg, mannitolum, polysorbatum 80, acidum tartaricum, natrii hydroxidum corresp. natrium max. 1.91 mg, acidum hydrochloridum, pro vitro.
Articles (1)
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
100.0 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 381.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 67756
- Drug name
- Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- J02AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANIDULAFUNGIN Labatec subst sèche 100 mg flac
- Description (DE)
- ANIDULAFUNGIN Labatec Trockensub 100 mg Durchstf
- Market launch
- 21/12/2020
- Narcotic (BTM)
- No